3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one

C71H64F2N18O5Se — CID 162052479

IUPAC3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one
SMILESC.Cc1ccc(CCC(=O)c2nn(C)c3cccnc3c2=O)cc1.Cn1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(=[Se])c2ncccc21.[H]/N=c1/c(-c2nnc(Cc3ccc(F)cc3)o2)nn(C)c2cccnc12.[H]/N=c1/c(C(=O)CCc2ccc(C)cc2)nn(C)c2cccnc12
InChIInChI=1S/C18H18N4O.C18H17N3O2.C17H13FN6O.C17H12FN5OSe.CH4/c1-12-5-7-13(8-6-12)9-10-15(23)18-16(19)17-14(22(2)21-18)4-3-11-20-17;1-12-5-7-13(8-6-12)9-10-15(22)17-18(23)16-14(21(2)20-17)4-3-11-19-16;1-24-12-3-2-8-20-15(12)14(19)16(23-24)17-22-21-13(25-17)9-10-4-6-11(18)7-5-10;1-23-12-3-2-8-19-14(12)16(25)15(22-23)17-21-20-13(24-17)9-10-4-6-11(18)7-5-10;/h3-8,11,19H,9-10H2,1-2H3;3-8,11H,9-10H2,1-2H3;2-8,19H,9H2,1H3;2-8H,9H2,1H3;1H4/b19-16+;;19-14+;;
InChIKeyYYSNICSJNSXMTJ-BSJLZUCFSA-N
MW1366.37 g/mol
LogP10.34
Rot. Bonds14

About 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one

3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one (PubChem CID 162052479) has the molecular formula C71H64F2N18O5Se and a molecular weight of 1366.37 g/mol. Its IUPAC name is 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one.

Molecular Properties

Compound Name3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one
PubChem CID162052479
Molecular FormulaC71H64F2N18O5Se
Molecular Weight1366.37 g/mol
Exact Mass1366.44
IUPAC Name3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one
SMILESC.Cc1ccc(CCC(=O)c2nn(C)c3cccnc3c2=O)cc1.Cn1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(=[Se])c2ncccc21.[H]/N=c1/c(-c2nnc(Cc3ccc(F)cc3)o2)nn(C)c2cccnc12.[H]/N=c1/c(C(=O)CCc2ccc(C)cc2)nn(C)c2cccnc12
InChIInChI=1S/C18H18N4O.C18H17N3O2.C17H13FN6O.C17H12FN5OSe.CH4/c1-12-5-7-13(8-6-12)9-10-15(23)18-16(19)17-14(22(2)21-18)4-3-11-20-17;1-12-5-7-13(8-6-12)9-10-15(22)17-18(23)16-14(21(2)20-17)4-3-11-19-16;1-24-12-3-2-8-20-15(12)14(19)16(23-24)17-22-21-13(25-17)9-10-4-6-11(18)7-5-10;1-23-12-3-2-8-19-14(12)16(25)15(22-23)17-21-20-13(24-17)9-10-4-6-11(18)7-5-10;/h3-8,11,19H,9-10H2,1-2H3;3-8,11H,9-10H2,1-2H3;2-8,19H,9H2,1H3;2-8H,9H2,1H3;1H4/b19-16+;;19-14+;;
InChIKeyYYSNICSJNSXMTJ-BSJLZUCFSA-N
XLogP10.34
TPSA299.59 Ų
H-Bond Donors2
H-Bond Acceptors23
Rotatable Bonds14
Heavy Atoms97
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001366.37
LogP ≤ 510.34
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one?
The IUPAC name of 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one (CID 162052479) is 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one.
What is the SMILES notation for 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one?
The canonical SMILES for 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one is C.Cc1ccc(CCC(=O)c2nn(C)c3cccnc3c2=O)cc1.Cn1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(=[Se])c2ncccc21.[H]/N=c1/c(-c2nnc(Cc3ccc(F)cc3)o2)nn(C)c2cccnc12.[H]/N=c1/c(C(=O)CCc2ccc(C)cc2)nn(C)c2cccnc12.
What is the InChIKey of 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one?
The InChIKey is YYSNICSJNSXMTJ-BSJLZUCFSA-N. The full InChI is InChI=1S/C18H18N4O.C18H17N3O2.C17H13FN6O.C17H12FN5OSe.CH4/c1-12-5-7-13(8-6-12)9-10-15(23)18-16(19)17-14(22(2)21-18)4-3-11-20-17;1-12-5-7-13(8-6-12)9-10-15(22)17-18(23)16-14(21(2)20-17)4-3-11-19-16;1-24-12-3-2-8-20-15(12)14(19)16(23-24)17-22-21-13(25-17)9-10-4-6-11(18)7-5-10;1-23-12-3-2-8-19-14(12)16(25)15(22-23)17-21-20-13(24-17)9-10-4-6-11(18)7-5-10;/h3-8,11,19H,9-10H2,1-2H3;3-8,11H,9-10H2,1-2H3;2-8,19H,9H2,1H3;2-8H,9H2,1H3;1H4/b19-16+;;19-14+;;.
What are the key properties of 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one?
3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one has a molecular weight of 1366.37 g/mol, XLogP of 10.34, 14 rotatable bonds, 2 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazine-4-selone;3-[5-[(4-fluorophenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-methylpyrido[3,2-c]pyridazin-4-imine;1-(4-imino-1-methylpyrido[3,2-c]pyridazin-3-yl)-3-(4-methylphenyl)propan-1-one;methane;1-methyl-3-[3-(4-methylphenyl)propanoyl]pyrido[3,2-c]pyridazin-4-one is sourced from PubChem (CID 162052479), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).